Plain-English translation of NCT07291076 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is a research study testing a new medication called to see if it is safe and works well for people with advanced or unresectable liver cancer. You may receive by itself, or combined with another immune-boosting medication called . Researchers want to understand how well this treatment works and what side effects it may cause.
Advanced liver cancer is difficult to treat, and many patients need better options. This trial is investigating whether this new medication can help people whose cancer cannot be surgically removed and who have not yet received systemic (whole-body) cancer treatment.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication alone or combined with the second drug. You will visit the clinic regularly for check-ups, blood tests, and imaging scans to monitor how well the treatment is working and to watch for any side effects. The study team will carefully track your health throughout the trial and adjust your care as needed.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States